ClinConnect ClinConnect Logo
Search / Trial NCT03020485

The Glycaemic Effect of Isomaltulose Consumption in Healthy Participants

Launched by SINGAPORE INSTITUTE OF FOOD AND BIOTECHNOLOGY INNOVATION · Jan 11, 2017

Trial Information

Current as of June 18, 2025

Completed

Keywords

ClinConnect Summary

The objective of the present study is to investigate the glycaemic effect of isomaltulose in Chinese, Indians, Malays and Caucasians. This will be a single intervention. Up to fifty participants, consisting of at least ten Chinese, ten Malays, ten Indians, and ten Caucasians completed data sets, aged between 21 and 40 years will be recruited from the general public in Singapore. Participants will be asked to attend two test sessions for this study. Participants will consume either a sucrose drink or an isomaltulose drink (each containing 50 g of available carbohydrate).

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Chinese, Indian, Malay or Caucasian ethnic origin
  • Exclusion Criteria:
  • People with major chronic disease such as heart disease, cancer or diabetes mellitus
  • Individuals with food intolerances or allergies to isomaltulose or sucrose
  • Individuals who are taking insulin or drugs known to affect glucose metabolism and body fat distribution
  • People with a major medical or surgical event requiring hospitalization within the preceding 3 months
  • Individuals with the presence of disease or drugs which influence digestion and absorption of nutrients
  • Pregnant women

About Singapore Institute Of Food And Biotechnology Innovation

The Singapore Institute of Food and Biotechnology Innovation (SIFBI) is a leading research organization dedicated to advancing the fields of food science and biotechnology. As a prominent sponsor of clinical trials, SIFBI focuses on innovative solutions that enhance food safety, quality, and sustainability, leveraging cutting-edge technologies to address global challenges in nutrition and health. With a multidisciplinary team of experts, SIFBI collaborates with industry partners and academic institutions to translate research findings into practical applications, fostering the development of functional foods and bio-based products that promote well-being and improve public health outcomes.

Locations

Patients applied

0 patients applied

Trial Officials

Melvin Leow, MD

Principal Investigator

Clinical Nutrition Research Centre

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials